1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. HALOZYME THERAPEUTICS INC.
Halozyme Therapeutics Inc. XNAS: HALO
56.80 -0.85 (-1.47%)
319.9K
XNAS Volume

XNAS 15 Jul, 2025 12:47 PM (EDT)

Insider Trade
Helen Torley, President & CEO of Halozyme Therapeutics, sells 60K shares worth $3.4 million See details

Detailed Stock Analysis for Halozyme Therapeutics Inc. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in